Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
1.
Metabolism ; 50(9): 1043-8, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11555836

ABSTRACT

Superoxide has been implicated in the cellular signalling pathways, which regulate growth of mesangial cells (MC) and vascular smooth muscle cells. Manganese (Mn)(2+)-dependent superoxide dismutase (SOD-2) is primarily responsible for metabolism of superoxide produced in mitochondria by respiratory chain activity during aerobic metabolism of glucose and other substrates. In the current studies, we examined the role of superoxide in the stimulation of collagen accumulation induced in MC by culture in media containing a high concentration of glucose. Aconitase, an iron sulfur enzyme whose activity is inhibited by superoxide, was used as an index of cellular superoxide production and action. SV-40-transformed mouse MC were cultured in media containing 100 (low) or 500 (high) mg/dL D-glucose and infected with a recombinant adenoviral (Ad) vector encoding either human mitochondrial Mn(2+) SOD-2 or green fluorescent protein (GFP). In cells infected with SOD-2 (SOD-2-Ad) and cultured in low glucose, SOD-2 activity was 5-fold higher than in cells infected with GFP (GFP-Ad), whereas Cu(2+)/Zn(2+) cytoplasmic SOD (SOD-1) did not differ; culture in high-glucose media did not alter SOD-2 or SOD-1 activity in either GFD-Ad or SOD-2-Ad. In GFP-Ad, high glucose suppressed aconitase activity and increased collagen accumulation compared with corresponding values in low glucose. In SOD-2-Ad, high glucose failed to suppress aconitase activity or increase collagen accumulation. Addition of exogenous (presumably extracellular) SOD to GFP-Ad had no effect on the stimulation of collagen accumulation by high glucose. Analogous to the effects of SOD-2-Ad, diphenylene iodonium (DPI), a nonspecific inhibitor of the production of superoxide by mitochondrial respiration and other nicotinamide adenine dinucleotide (phosphate) (NAD)(P)H oxidase activities, reduced collagen accumulation in GFP-Ad cultured in low glucose and blocked stimulation of collagen accumulation induced by culture in high glucose. These results support a role for increased cellular superoxide production derived from NAD(P)H oxidase activity in the stimulation of collagen accumulation induced in MC by high glucose and demonstrate that an increase in mitochondrial SOD-2 activity suppresses this response.


Subject(s)
Collagen/metabolism , Glomerular Mesangium/metabolism , Glucose/metabolism , Superoxide Dismutase/biosynthesis , Aconitate Hydratase/metabolism , Adenoviridae/genetics , Animals , Cells, Cultured , Culture Media/pharmacology , Enzyme Activation/drug effects , Gene Expression , Glomerular Mesangium/cytology , Glomerular Mesangium/drug effects , Glucose/pharmacology , Green Fluorescent Proteins , Humans , Luminescent Proteins/biosynthesis , Luminescent Proteins/genetics , Mice , NADPH Oxidases/metabolism , Onium Compounds/pharmacology , Superoxide Dismutase/genetics , Superoxide Dismutase-1 , Transfection , Transgenes
2.
Arch Otolaryngol Head Neck Surg ; 127(9): 1075-9, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11556855

ABSTRACT

BACKGROUND: Salivary duct carcinoma (SDC) is a rare, highly aggressive neoplasm that primarily affects the major salivary glands. It is a distinct clinicopathological entity characterized by its morphologic resemblance to ductal carcinoma of the breast, a high incidence of regional lymph node metastasis, and distant dissemination. Frequent expression of androgen receptor (AR) but not estrogen receptor or progesterone receptor in SDCs suggests that SDC bears a close immunophenotypic homology with prostatic carcinoma. An AR-mediated autocrine growth pathway consisting of epidermal growth factor receptor (EGFR) and its ligand, transforming growth factor alpha (TGF-alpha), has been implicated in the carcinogenesis of prostatic carcinoma. Androgens, in the presence of AR, mediate their mitogenic effects on prostatic cancer cells by up-regulating the transcriptional and translational activities of EGFR and TGF-alpha. Through an autocrine mode of action, TGF-alpha produced in the tumor cells binds to its receptor, EGFR, which is also expressed by these cells, resulting in a proliferative response. OBJECTIVE: To investigate whether a TGF-alpha/EGFR autocrine pathway is present in SDCs. DESIGN: Retrospective analysis of the expression of AR, EGFR, and TGF-alpha in 12 SDCs. SETTING: An academic medical center. RESULTS: Salivary duct carcinoma expresses AR, TGF-alpha, and EGFR in 11 (92%), 8 (67%), and 11 (92%) of 12 cases, respectively. CONCLUSION: An AR-mediated TGF-alpha/EGFR autocrine pathway may be implicated in the tumorigenesis of SDC.


Subject(s)
Carcinoma/metabolism , ErbB Receptors/biosynthesis , Receptors, Androgen/biosynthesis , Salivary Gland Neoplasms/metabolism , Transforming Growth Factor alpha/biosynthesis , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Retrospective Studies
3.
Diabetes ; 50(9): 2114-25, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11522679

ABSTRACT

Ex vivo and in vitro observations implicate superoxide as a mediator of cell injury in diabetes, but in vivo evidence is lacking. In the current studies, parameters of glomerular injury were examined in hemizygous nondiabetic transgenic mice (SOD) and streptozotocin-diabetic (D) transgenic mice (D-SOD), which overexpress human cytoplasmic Cu2+/Zn2+ superoxide dismutase (SOD-1), and in corresponding wild-type littermates (WT, D-WT) after 4 months of diabetes. In both SOD and D-SOD mice, renal cortical SOD-1 activity was twofold higher than values in the WT mice; blood glucose and glycosylated hemoglobin (GHb) levels did not differ in the two diabetic groups. Urinary albumin excretion, fractional albumin clearance, urinary transforming growth factor-beta (TGF-beta) excretion, glomerular volume, glomerular content of immunoreactive TGF-beta, and collagen alpha1 (IV) and renal cortical malondialdehyde (MDA) levels were significantly higher in D-WT mice compared with corresponding values in D-SOD mice. Glomerular volume, glomerular content of TGF-beta and collagen IV, renal cortical MDA, and urinary excretion of TGF-beta in D-SOD mice did not differ significantly from corresponding values in either the nondiabetic SOD or WT mice. In separate groups of mice studied after 8 months of diabetes, mesangial matrix area, calculated as a fraction of total glomerular tuft area, and plasma creatinine were significantly higher in D-WT but not in D-SOD mice, compared with corresponding values in the nondiabetic mice. In vitro infection of mesangial cells (MC) with a recombinant adenovirus encoding human SOD-1 increased SOD-1 activity threefold over control cells and prevented the reduction of aconitase activity, an index of cellular superoxide, and the increase in collagen synthesis that otherwise occurred in control MC in response to culture with 300 or 500 mg/dl glucose. Thus, increases in cellular SOD-1 activity attenuate diabetic renal injury in vivo and also prevent stimulation of MC matrix protein synthesis induced in vitro by high glucose.


Subject(s)
Diabetic Nephropathies/prevention & control , Kidney Glomerulus/drug effects , Superoxide Dismutase/metabolism , Aconitate Hydratase/metabolism , Animals , Cells, Cultured , Collagen/antagonists & inhibitors , Creatinine/blood , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/pathology , Diabetic Nephropathies/etiology , Glomerular Mesangium/drug effects , Glomerular Mesangium/metabolism , Glomerular Mesangium/pathology , Glucose/pharmacology , Humans , Kidney Cortex/enzymology , Mice , Mice, Inbred C57BL , Mice, Transgenic/genetics , Oxidation-Reduction/drug effects , Reference Values , Superoxide Dismutase/genetics
4.
Br J Cancer ; 85(2): 235-41, 2001 Jul 20.
Article in English | MEDLINE | ID: mdl-11461083

ABSTRACT

Mutations in the K- ras gene are very common in lung tumours and are implicated in the development of lung cancer, but the timing of their occurrence remains poorly understood. We investigated K- ras mutations in cell samples microdissected by laser capture microscopy at multiple sites from lung tissue sections representing tumour tissue and matched histologically normal tissue obtained from 48 lung cancer patients. K- ras mutations were detected in cell samples from 10 of 38 (26.3%) lung adenocarcinomas and in none of the histologically normal or tumour cell samples taken from 10 lung squamous cell carcinomas. Of the K- ras mutation-positive adenocarcinomas, in 4 cases a mutation was found in only the tumour tissue, in 1 case a mutation was found only in the histologically normal tissue, and in 5 cases mutations were found in both the tumour tissue and histologically normal tissue. Among these 5 cases, 2 had identical mutations in both the tumour tissue and histologically normal tissue, 2 had 1 mutation in the tumour tissue and 2 mutations in the histologically normal tissue, 1 of which was identical to the mutation found in the tumour, and 1 case had 2 codon 12 mutations in tumour tissue and 2 mutations, in codons 9 and 11, in histologically normal tissue. These results showed that K- ras mutations are frequent in histologically normal cells taken from outside lung adenocarcinomas and suggest that some of these mutations may represent early events which could pave the way of lung carcinogenesis.


Subject(s)
Adenocarcinoma/genetics , Genes, ras , Lung Neoplasms/genetics , Mutation , Adenocarcinoma/pathology , Electrophoresis, Polyacrylamide Gel , Humans , Lung Neoplasms/pathology , Polymerase Chain Reaction
5.
Mol Cell ; 6(2): 293-306, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10983977

ABSTRACT

We have generated mice deficient in E2F4 activity, the major form of E2F in many cell types. Analysis of newborn pups deficient in E2F4 revealed abnormalities in hematopoietic lineage development as well as defects in the development of the gut epithelium. Specifically, we observed a deficiency of various mature hematopoietic cell types together with an increased number of immature cells in several lineages. This was associated with an increased frequency of apoptotic cells. We also found a substantial reduction in the thickness of the gut epithelium that normally gives rise to crypts as well as a reduction in the density of villi. These observations suggest a critical role for E2F4 activity in controlling the maturation of cells in a number of tissues.


Subject(s)
Abnormalities, Multiple/genetics , DNA-Binding Proteins/metabolism , Hematopoietic Stem Cells/cytology , Intestinal Mucosa/abnormalities , Transcription Factors/metabolism , Animals , Animals, Newborn , Bone Marrow/embryology , Bone Marrow Cells/cytology , Bone Marrow Cells/pathology , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/genetics , E2F4 Transcription Factor , Embryonic and Fetal Development/genetics , Growth Disorders/genetics , Mice , Mice, Knockout , Transcription Factors/deficiency , Transcription Factors/genetics
6.
Clin Cancer Res ; 6(7): 2794-802, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10914726

ABSTRACT

The expression of human leukocyte antigen (HLA) class I molecules on the cell surface is necessary for the presentation of peptide antigens to cytotoxic CD8+ T lymphocytes of the immune system. Down-regulation of HLA class I gene expression has been implicated in tumorigenesis, including squamous cell carcinoma of the head and neck (SCCHN). Loss of MHC class I antigens may be one mechanism by which tumor cells escape immune detection. We performed prospective immunostaining of 26 primary SCCHN tumors and samples of normal mucosa harvested several centimeters away from the primary tumor, using a large panel of antibodies directed against allele-specific as well as monomorphic determinants of HLA class I molecules. Loss of expression of HLA class I proteins in the tumor was found in 50% (13 of 26) of primary tumors and was highly correlated with HLA loss in the corresponding normal mucosa (P < 0.0001). Further analysis demonstrated that the loss of HLA class I expression in the tumor was significantly associated with regional lymph node metastases (nodal stage; P = 0.0388), and that the number of HLA class I alleles lost in the normal mucosa was associated with subsequent development of a new primary aerodigestive tract cancer (P = 0.042). A patient with two metachronous cancers available for analysis had no evidence of HLA loss in the first tumor, demonstrated allelic loss in the second cancer, and subsequently died of disease. These results suggest that the loss of expression of HLA class I alleles may have prognostic implications.


Subject(s)
Carcinoma, Squamous Cell/genetics , Genes, MHC Class I , Head and Neck Neoplasms/genetics , Histocompatibility Antigens Class I/analysis , Loss of Heterozygosity , Adult , Aged , Aged, 80 and over , Alleles , Carcinoma, Squamous Cell/immunology , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/therapy , Combined Modality Therapy , Female , Haplotypes , Head and Neck Neoplasms/immunology , Head and Neck Neoplasms/pathology , Head and Neck Neoplasms/therapy , Histocompatibility Antigens Class I/genetics , Histocompatibility Testing , Humans , Male , Middle Aged , Mucous Membrane/immunology , Mucous Membrane/pathology , Neoplasm Staging
7.
Proc Natl Acad Sci U S A ; 97(8): 4227-32, 2000 Apr 11.
Article in English | MEDLINE | ID: mdl-10760290

ABSTRACT

Field cancerization predisposes the upper aerodigestive tract mucosa to the formation of multiple primary tumors, when exposed to environmental carcinogens. Up-regulation of epidermal growth factor receptor occurs early in squamous cell carcinogenesis and is critical for the loss of growth control in a variety of human cancers, including head and neck squamous cell carcinomas. In these tumor cells in culture, epidermal growth factor receptor stimulation initiates signaling via persistent activation of selective STAT proteins. To determine the timing of Stat3 activation in head and neck carcinogenesis, we studied the expression and constitutive activation of Stat3 in tumors and normal mucosa from patients with head and neck cancer compared with mucosa from controls without cancer. Stat3 was up-regulated and constitutively activated in both primary human head and neck tumors as well as in normal mucosa from these cancer patients compared with control normal mucosa from patients without cancer. In vivo liposome-mediated gene therapy with a Stat3 antisense plasmid efficiently inhibited Stat3 activation, increased tumor cell apoptosis, and decreased Bcl-x(L) expression in a head and neck xenograft model. These findings provide evidence that constitutively activated Stat3 is an early event in head and neck carcinogenesis that contributes to the loss of growth control by an anti-apoptotic mechanism.


Subject(s)
Apoptosis , Carcinoma, Squamous Cell/pathology , DNA-Binding Proteins/metabolism , Head and Neck Neoplasms/pathology , Signal Transduction , Trans-Activators/metabolism , Animals , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/therapy , DNA-Binding Proteins/genetics , ErbB Receptors/metabolism , Female , Genetic Therapy , Head and Neck Neoplasms/genetics , Head and Neck Neoplasms/therapy , Humans , Liposomes , Mice , Mice, Nude , Neoplasm Transplantation , Oligonucleotides, Antisense/pharmacology , STAT3 Transcription Factor , Trans-Activators/genetics , Transforming Growth Factors/metabolism , Tumor Cells, Cultured
8.
Gene Ther ; 7(22): 1906-14, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11127578

ABSTRACT

Unlike normal mucosal squamous epithelial cells, head and neck squamous cell carcinomas (HNSCCs) overexpress TGF-alpha mRNA and protein which is required to sustain the proliferation of HNSCC cells in vitro. To determine whether TGF-alpha expression contributes to tumor growth in vivo, cationic liposome-mediated gene transfer was used to deliver an antisense expression construct targeting the human TGF-alpha gene into human head and neck tumor cells, grown as subcutaneous xenografts in nude mice. The TGF-alpha antisense gene was immediately detected in the cytoplasm of the tumor cells, translocated to the nucleus by 12 h and remained localized to the nucleus for up to 3 days. Direct inoculation of the TGF-alpha antisense (but not the corresponding sense) construct into established HNSCC tumors resulted in inhibition of tumor growth. Sustained antitumor effects were observed for up to 1 year after the treatments were discontinued. Down-modulation of TGF-alpha was accompanied by increased apoptosis in vivo. These experiments indicate that interference with the TGF-alpha/EGFR autocrine signaling pathway may be an effective therapeutic strategy for cancers which overexpress this ligand/receptor pair.


Subject(s)
Carcinoma, Squamous Cell/therapy , Genetic Therapy/methods , Head and Neck Neoplasms/therapy , Oligonucleotides, Antisense/administration & dosage , Transfection/methods , Transforming Growth Factor alpha/genetics , Animals , Apoptosis , Cell Division , Cell Line , Gene Expression , Humans , Mice , Mice, Nude , Microscopy, Fluorescence , Neoplasms, Experimental/therapy , Random Allocation , Xenograft Model Antitumor Assays
9.
Dev Biol ; 210(2): 481-96, 1999 Jun 15.
Article in English | MEDLINE | ID: mdl-10357905

ABSTRACT

Similarities in the differentiation of mouse embryos and ES cell embryoid bodies suggest that aspects of early mammalian embryogenesis can be studied in ES cell embryoid bodies. In an effort to understand the regulation of cellular differentiation during early mouse embryogenesis, we altered the expression of the Pem homeobox-containing gene in ES cells. Pem is normally expressed in the preimplantation embryo and expressed in a lineage-restricted fashion following implantation, suggesting a role for Pem in regulating cellular differentiation in the early embryo. Here, we show that the forced expression of Pem from the mouse Pgk-1 promoter in ES cells blocks the in vitro and in vivo differentiation of the cells. In particular, embryoid bodies produced from these Pgk-Pem ES cells do not differentiate into primitive endoderm or embryonic ectoderm, which are prominent features of early embryoid bodies from normal ES cells. This Pgk-Pem phenotype is also different from the null phenotype, as embryoid bodies derived from ES cells in which endogenous Pem gene expression has been blocked show a pattern of differentiation similar to that of normal ES cells. When the Pgk-Pem ES cells were introduced into subcutaneous sites of nude mice, only undifferentiated EC-like cells were found in the teratomas derived from the injected cells. The Pem-dependent block of ES cell differentiation appears to be cell autonomous; Pgk-Pem ES cells did not differentiate when mixed with normal, differentiating ES cells. A block to ES cell differentiation, resulting from the forced expression of Pem, can also be produced by the forced expression of the nonhomeodomain region of Pem. These studies are consistent with a role for Pem in regulating the transition between undifferentiated and differentiated cells of the early mouse embryo.


Subject(s)
Cell Differentiation , Genes, Homeobox , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Stem Cells/cytology , Teratoma/pathology , Transcription Factors/genetics , Transcription Factors/metabolism , Animals , Blastocyst/physiology , Cells, Cultured , Embryonic and Fetal Development , Exons , Mice , Mice, Nude , Morphogenesis , Phosphoglycerate Kinase/genetics , Promoter Regions, Genetic , Recombinant Proteins/metabolism , Stem Cells/physiology , Teratoma/genetics , Transfection , X Chromosome
10.
Proc Natl Acad Sci U S A ; 95(25): 14717-22, 1998 Dec 08.
Article in English | MEDLINE | ID: mdl-9843955

ABSTRACT

Wnt family members are critical to many developmental processes, and components of the Wnt signaling pathway have been linked to tumorigenesis in familial and sporadic colon carcinomas. Here we report the identification of two genes, WISP-1 and WISP-2, that are up-regulated in the mouse mammary epithelial cell line C57MG transformed by Wnt-1, but not by Wnt-4. Together with a third related gene, WISP-3, these proteins define a subfamily of the connective tissue growth factor family. Two distinct systems demonstrated WISP induction to be associated with the expression of Wnt-1. These included (i) C57MG cells infected with a Wnt-1 retroviral vector or expressing Wnt-1 under the control of a tetracyline repressible promoter, and (ii) Wnt-1 transgenic mice. The WISP-1 gene was localized to human chromosome 8q24.1-8q24.3. WISP-1 genomic DNA was amplified in colon cancer cell lines and in human colon tumors and its RNA overexpressed (2- to >30-fold) in 84% of the tumors examined compared with patient-matched normal mucosa. WISP-3 mapped to chromosome 6q22-6q23 and also was overexpressed (4- to >40-fold) in 63% of the colon tumors analyzed. In contrast, WISP-2 mapped to human chromosome 20q12-20q13 and its DNA was amplified, but RNA expression was reduced (2- to >30-fold) in 79% of the tumors. These results suggest that the WISP genes may be downstream of Wnt-1 signaling and that aberrant levels of WISP expression in colon cancer may play a role in colon tumorigenesis.


Subject(s)
Colonic Neoplasms/genetics , Gene Expression Regulation, Neoplastic , Growth Substances/genetics , Immediate-Early Proteins , Intercellular Signaling Peptides and Proteins , Oncogene Proteins , Proto-Oncogene Proteins/genetics , Zebrafish Proteins , Amino Acid Sequence , Animals , CCN Intercellular Signaling Proteins , Cell Line, Transformed , Connective Tissue Growth Factor , DNA, Complementary/genetics , Humans , Intracellular Signaling Peptides and Proteins , Mice , Molecular Sequence Data , Sequence Alignment , Transfection , Tumor Cells, Cultured , Wnt Proteins , Wnt1 Protein
11.
Clin Cancer Res ; 4(11): 2913-21, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9829760

ABSTRACT

Aberrant regulation of apoptosis may contribute to tumorigenesis. Relative levels of apoptosis regulatory proteins, such as Bcl-2 and Bax as well as interactions of these proteins with other gene products, may contribute to the rate of apoptosis in neoplasia. We examined Bcl-2 expression in 104 squamous cell carcinomas of the head and neck, as well as histologically normal mucosa several centimeters away from the tumor, and in control normal mucosa from patients without cancer. Immunohistochemistry and immunoblotting demonstrated Bcl-2 expression in 30% (31 of 104) of squamous cell carcinoma, with an increase in Bcl-2 protein levels compared with control normal mucosa from noncancer patients. Bcl-2-positive tumors demonstrated a 5-fold decrease in the number of apoptotic cells compared with Bcl-2-negative tumors. Bcl-2 protein expression was associated with poorly differentiated tumor grade but was not correlated with Bax expression or patient survival. These findings demonstrate that Bcl-2 contributes to apoptosis in normal and transformed squamous epithelium.


Subject(s)
Apoptosis , Carcinoma, Squamous Cell/pathology , Head and Neck Neoplasms/pathology , Proto-Oncogene Proteins c-bcl-2/physiology , Proto-Oncogene Proteins/physiology , Adult , Aged , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/metabolism , Cell Line, Transformed , Epithelium/metabolism , Epithelium/pathology , Female , Gene Expression Regulation, Neoplastic , Head and Neck Neoplasms/genetics , Head and Neck Neoplasms/metabolism , Humans , Immunohistochemistry , Male , Middle Aged , Mucous Membrane/metabolism , Mucous Membrane/pathology , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Proto-Oncogene Proteins/biosynthesis , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins c-bcl-2/genetics , bcl-2-Associated X Protein
12.
J Natl Cancer Inst ; 90(14): 1080-7, 1998 Jul 15.
Article in English | MEDLINE | ID: mdl-9672256

ABSTRACT

BACKGROUND: Squamous cell carcinomas of the head and neck (SCCHN), unlike normal mucosal squamous epithelial cells, overexpress epidermal growth factor receptor (EGFR) messenger RNA and protein. EGFR protein is required to sustain the proliferation of SCCHN cells in vitro. To determine whether EGFR expression contributes to tumor growth, we investigated the effect of suppressing EGFR expression in tumor xenografts through in situ expression of antisense oligonucleotides. METHODS: Intratumoral cationic liposome-mediated gene transfer was used to deliver plasmids capable of expressing sense or antisense EGFR sequences into human head and neck tumors, which were grown as subcutaneous xenografts in nude mice. The oligonucleotides were expressed under the control of the U6 RNA promoter. RESULTS: Direct inoculation of the EGFR antisense (but not the corresponding sense) plasmid construct into established SCCHN xenografts resulted in inhibition of tumor growth, suppression of EGFR protein expression, and an increased rate of apoptosis (programmed cell death). Sustained antitumor effects were observed for up to 2 weeks after the treatments were discontinued. CONCLUSION: These results suggest that interference with EGFR expression, using an antisense-based gene therapy approach, may be an effective means of treating EGFR-overexpressing tumors, including SCCHN.


Subject(s)
Carcinoma, Squamous Cell/therapy , ErbB Receptors/genetics , Genetic Therapy/methods , Head and Neck Neoplasms/therapy , Promoter Regions, Genetic , RNA, Antisense/genetics , RNA, Antisense/therapeutic use , Animals , Carcinoma, Squamous Cell/genetics , ErbB Receptors/biosynthesis , Female , Gene Expression Regulation, Neoplastic , Head and Neck Neoplasms/genetics , Humans , Mice , Mice, Nude , Neoplasm Transplantation , Polymerase Chain Reaction , RNA, Messenger/genetics , RNA, Neoplasm/genetics , RNA-Directed DNA Polymerase , Recombinant Fusion Proteins/genetics , Ribonucleoprotein, U4-U6 Small Nuclear/genetics , Transcription, Genetic
13.
J Natl Cancer Inst ; 90(11): 824-32, 1998 Jun 03.
Article in English | MEDLINE | ID: mdl-9625170

ABSTRACT

BACKGROUND: The most accurate predictor of disease recurrence in patients treated for head and neck squamous cell carcinoma is, at present, the extent of regional lymph node metastasis. Since elevated levels of epidermal growth factor receptor (EGFR) and of its ligand, transforming growth factor-alpha (TGF-alpha), have been detected in primary tumors of patients with head and neck squamous cell carcinoma, we determined whether tumor levels of these proteins were of prognostic importance. METHODS: Monoclonal antibodies specific for EGFR and TGF-alpha were used for immunohistochemical detection of each protein in tissue sections of primary tumors from 91 patients who were treated by surgical resection. Levels of immunoreactive EGFR and TGF-alpha were quantified by use of a computerized image analysis system and were normalized to appropriate standards. The logrank test and proportional hazards regression analysis were used to calculate the probability that EGFR and TGF-alpha levels were associated with disease-free survival (i.e., no recurrence of cancer) and cause-specific survival (i.e., patients do not die of their disease). All P values were two-sided. RESULTS: When tumor levels of EGFR or TGF-alpha were analyzed as continuous variables, disease-free survival and cause-specific survival were reduced among patients with higher levels of EGFR (both P = .0001) or TGF-alpha (both P = .0001). In a multivariate analysis, tumor site, tumor level of EGFR, and tumor level of TGF-alpha were statistically significant predictors of disease-free survival; in a similar analysis, regional lymph node stage and tumor levels of EGFR and of TGF-alpha were significant predictors of cause-specific survival. CONCLUSION: Quantitation of EGFR and TGF-alpha protein levels in primary head and neck squamous cell carcinomas may be useful in identifying subgroups of patients at high risk of tumor recurrence and in guiding therapy.


Subject(s)
Biomarkers, Tumor/analysis , Carcinoma, Squamous Cell/chemistry , ErbB Receptors/analysis , Head and Neck Neoplasms/chemistry , Neoplasm Proteins/analysis , Transforming Growth Factor alpha/analysis , Adult , Aged , Antibodies, Monoclonal/immunology , Biomarkers, Tumor/biosynthesis , Biomarkers, Tumor/immunology , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/therapy , Disease-Free Survival , ErbB Receptors/biosynthesis , ErbB Receptors/immunology , Female , Gene Expression Regulation, Neoplastic , Head and Neck Neoplasms/mortality , Head and Neck Neoplasms/therapy , Humans , Immunohistochemistry , Life Tables , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Invasiveness , Neoplasm Recurrence, Local/epidemiology , Proportional Hazards Models , Retrospective Studies , Survival Analysis , Transforming Growth Factor alpha/biosynthesis , Transforming Growth Factor alpha/immunology
14.
Clin Cancer Res ; 4(1): 13-20, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9516947

ABSTRACT

The development of head and neck squamous cell carcinoma occurs as a result of the accumulation of genotypic and phenotypic alterations in the upper aerodigestive tract mucosa. Up-regulation of epidermal growth factor receptor (EGFR) and its ligand, transforming growth factor alpha (TGF-alpha), have been identified previously as early events in head and neck carcinogenesis. To determine the timing of increased TGF-alpha and EGFR protein expression in the development of head and neck cancer, we examined progressive mucosal dysplasias from three distinct and complimentary patient groups: (a) samples from patients with lesions demonstrating different degrees of dysplasia (n = 22) compared with mucosa samples from gender and age-matched controls (n = 8); (b) patients with lesions demonstrating different degrees of dysplasia at a single time point (n = 3); and (c) patients who progressed over several years to invasive cancer at the site of dysplasia (n = 7). Immunohistochemical analysis with monoclonal antibodies specific for TGF-alpha and EGFR were used to detect protein expression in all specimens. Protein levels were further quantitated using a computerized image analysis system. In all three groups, we found that TGF-alpha protein levels were elevated in mild dysplasia compared with control normal mucosa and were not further modulated with increasing degrees of dysplasia. In contrast, EGFR levels were relatively low in mild dysplasia and increased with higher degrees of dysplasia. These findings indicate that up-regulation of TGF-alpha and EGFR are distinct events both chronologically and, possibly, mechanistically in the pathogenesis of head and neck squamous cell carcinoma.


Subject(s)
Carcinoma, Squamous Cell/chemistry , ErbB Receptors/analysis , Head and Neck Neoplasms/chemistry , Precancerous Conditions/chemistry , Transforming Growth Factor alpha/analysis , Carcinoma, Squamous Cell/pathology , Female , Head and Neck Neoplasms/pathology , Humans , Immunohistochemistry , Male , Precancerous Conditions/pathology
15.
J Cell Biochem ; 69(1): 55-62, 1998 Apr 01.
Article in English | MEDLINE | ID: mdl-9513046

ABSTRACT

Interruption of an autocrine growth pathway involving TGF-alpha and EGFR may inhibit tumor growth and improve survival in head and neck cancer patients. We previously demonstrated that biopsy specimens and established cell lines from patients with squamous cell carcinoma of the head and neck (SCCHN) overexpress TGF-alpha and its receptor, epidermal growth factor receptor (EGFR) at both the mRNA and protein levels. Protein localization studies showed that TGF-alpha and EGFR are produced by the same epithelial cells in tissues from head and neck cancer patients further supporting a role for this ligand-receptor pair in an autocrine growth pathway. To confirm that TGF-alpha contributes to autocrine growth, we examined the effect of down regulation of TGF-alpha protein on SCCHN cell proliferation. Treatment of 6 SCCHN cell lines with antisense oligodeoxynucleotides targeting the translation start site of human TGF-alpha mRNA decreased TGF-alpha protein production by up to 93% and reduced cell proliferation by a mean of 76.2% compared to a 9.7% reduction with sense oligonucleotide (range P = 0.036-0.0001). TGF-alpha antisense oligonucleotide exposure also decreased TGF-alpha protein levels in normal oropharyngeal mucosal epithelial cells, however their growth rate was not affected. These findings indicate that TGF-alpha is participating in an autocrine signaling pathway in transformed, but not in normal mucosal epithelial cells, that promotes proliferation.


Subject(s)
Carcinoma, Squamous Cell/drug therapy , Head and Neck Neoplasms/drug therapy , Transforming Growth Factor alpha/genetics , Transforming Growth Factor alpha/metabolism , Base Sequence , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/pathology , Cell Division/drug effects , Cell Transformation, Neoplastic , Down-Regulation , Epithelial Cells/cytology , Epithelial Cells/drug effects , Head and Neck Neoplasms/genetics , Head and Neck Neoplasms/pathology , Humans , Mucous Membrane/cytology , Mucous Membrane/drug effects , Oligonucleotides, Antisense/genetics , Oligonucleotides, Antisense/pharmacology , Signal Transduction , Tumor Cells, Cultured
16.
Oncogene ; 15(4): 409-16, 1997 Jul 24.
Article in English | MEDLINE | ID: mdl-9242377

ABSTRACT

Previous reports have shown that fresh tissues and cell lines from patients with squamous cell carcinoma of the head and neck (SCCHN) overexpress transforming growth factor alpha (TGF-alpha) and its receptor, the epidermal growth factor receptor (EGFR) at both the mRNA and protein levels. Protein localization studies confirm that TGF-alpha and EGFR are produced by the same epithelial cells in tissues from head and neck cancer patients further supporting an autocrine growth pathway. Using three strategies, we examined the hypothesis that downmodulation of EGFR would reduce the proliferation of SCCHN cells. We targeted EGFR mRNA using antisense oligonucleotides and the mature EGFR protein at two sites, the ligand-binding domain and the kinase domain, and determined the effects of this targeting on SCCHN proliferation. Treatment of several SCCHN cell lines with a pair of antisense oligodeoxynucleotides directed against the translation start site and first intron-exon splice junction of the human EGFR gene resulted in decreased EGFR protein production and inhibited growth by 86% compared to a 13% reduction in cells treated with sense oligonucleotides (P=0.03). Growth inhibition was specific for carcinoma cells since the same EGFR antisense oligonucleotides had no effect on the proliferation of normal mucosa cells harvested from non-cancer patients. Two monoclonal antibodies which block ligand binding to EGFR (MAbs 425 and 528) inhibited the growth of several SCCHN cell lines by up to 97% which suggests that EGFR is participating in an autocrine pathway in SCCHN that is, at least in part, external. An EGFR-specific tyrosine kinase inhibitor (PD 153035) was found to inhibit EGFR phosphorylation in SCCHN cell lines and to reduce growth by 68% although it had no effect on the growth rate of normal mucosal epithelial cells. These experiments indicate that EGFR gene expression and function is critical for SCCHN cell growth but not for growth of normal mucosa cells and therefore may serve as a tumor-specific target for preventive and therapeutic strategies in head and neck cancer.


Subject(s)
Carcinoma, Squamous Cell/pathology , ErbB Receptors/physiology , Head and Neck Neoplasms/pathology , Aged , Antibodies, Monoclonal/immunology , Cell Division , ErbB Receptors/genetics , Female , Humans , Male , Middle Aged , Mucous Membrane/cytology , Oligonucleotides, Antisense/pharmacology , Phosphorylation
17.
Cancer J Sci Am ; 3(1): 21-30, 1997.
Article in English | MEDLINE | ID: mdl-9072304

ABSTRACT

BACKGROUND: Prostate cancer is the most common cancer in American men and the second leading cause of cancer death. All clinical observations correlate poorly differentiated high-grade prostate cancer with disease-specific mortality. The HER2 cell membrane tyrosine kinase, a member of the epidermal growth factor receptor family that is the transcription product of the erbB2neu oncogene, and HER3, a receptor protein of the same family, are overexpressed in prostate cancer and prostatic intraepithelial neoplasia. The ligand for these receptors and another related family member, HER4, has recently been identified by independent investigator groups and called neu differentiation factor (NDF) or heregulin. In vitro treatment of HER2- and HER3- or HER2- and HER4-expressing breast cancer cells stimulates tyrosine phosphorylation of HER2 and produces changes in the rate of proliferation, degree of cellular differentiation, and synthesis of physiologic secretion products. There are no published reports on the expression of NDF and HER4 in prostate cancer or the in vitro effects of NDF in prostate cancer cells. METHODS: Expression of NDF, HER2, HER3, and HER4 was studied in 24 frozen prostatectomy specimens by immunohistochemistry. The biologic effect of human recombinant NDF was studied in vitro, using the LNCaP, PC3, and DU145 human prostate cancer cell lines. HER and NDF protein expression was studied by immunohistochemistry. NDF mRNA was analyzed using reverse transcriptase polymerase chain reaction from whole RNA. The biologic effects of NDF on prostate cancer cells in vitro included cell proliferation, thymidine synthesis, induction of prostate-specific antigen mRNA, anchorage-dependent and anchorage-independent cell growth, and ploidy analysis. Data analysis was performed using Student's t test. RESULTS: Observations in clinical prostatectomy specimens: Immunohistochemistry studies in clinical prostatectomy specimens demonstrate absence of significant NDF expression in prostate cancer, whereas it is expressed in 100% of the stroma, 100% of basal epithelial cells, and 58% of luminal cells in normal and benign hyperplastic prostatic tissue. The HER4 receptor protein is strongly expressed by normal prostate luminal cells, but not prostate cancer. Benign prostate tissue exhibits strong expression of HER2, HER3, and HER4 by basal cells, but only luminal cells significantly express HER4. Only 23% of prostate cancer specimens express HER4, while 95% express HER3 and 82% HER2. Prostatic intraepithelial neoplasia stained similarly to cancer for all proteins studied. Observations in prostate cancer cell lines: In vitro treatment with NDF significantly reduces aneuploidy and proliferation and growth of androgen-sensitive prostate cancer cells. Incubation with NDF also induces prostate-specific antigen mRNA in prostate cancer cells. In spite of displaying NDF mRNA, prostate cancer cells do not produce detectable NDF protein, but express HER2 and HER3 proteins. DISCUSSION: These data suggest that NDF may be a paracrine differentiation factor involved in normal adult prostate physiology and that functional loss of the NDF/HER ligand/ receptor loop may be an early event associated with prostate tumorigenesis.


Subject(s)
Antineoplastic Agents/metabolism , ErbB Receptors/biosynthesis , Glycoproteins/biosynthesis , Prostatic Neoplasms/metabolism , Proto-Oncogene Proteins/biosynthesis , Cell Division , Flow Cytometry , Humans , Immunohistochemistry , Male , Neuregulins , Nucleic Acid Synthesis Inhibitors , Ploidies , Prostate/cytology , Prostate/metabolism , Prostatic Neoplasms/chemistry , Prostatic Neoplasms/pathology , Prostatic Neoplasms/surgery , Receptor, ErbB-2/biosynthesis , Receptor, ErbB-3 , Tumor Cells, Cultured
18.
Dig Dis Sci ; 42(12): 2453-62, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9440619

ABSTRACT

We sought to determine if an immunohistochemical panel of p53, PCNA, and c-erbB-2 was a useful biomarker of transformation in Barrett's metaplasia. P53, PCNA, and c-erbB-2 immunohistochemistry was performed on resected Barrett's specimens selected to show discrete grades of dysplasia and then on prospectively obtained biopsies. In resection specimens, p53 was positive in 36% with no dysplasia, in 30% with low-grade dysplasia, in 85% with high-grade dysplasia, and in 90% of adenocarcinomas. While an evaluation of proliferation throughout the specimen did not differ between groups, surface proliferation was significantly higher in high-grade dysplasia than in low-grade or no dysplasia. All high-grade dysplasia specimens were positive for at least one marker, compared to 44% with no or low-grade dysplasia. C-erbB-2 was only seen in 31% with high-grade dysplasia and in 10% of adenocarcinomas. Prospectively, the panel had a sensitivity of 100%, a specificity of 81% and an overall accuracy of 83% in identifying patients who developed high-grade dysplasia or cancer. Thus, overexpression of p53 occurs early in the malignant transformation of Barrett's and increases with histologic progression, and proliferation at the surface of Barrett's epithelium increases with progressive grades of dysplasia. An immunohistochemical panel of p53 and PCNA is a useful biomarker for Barrett's metaplasia.


Subject(s)
Adenocarcinoma/genetics , Barrett Esophagus/genetics , Esophageal Neoplasms/genetics , Proliferating Cell Nuclear Antigen/analysis , Receptor, ErbB-2/analysis , Tumor Suppressor Protein p53/analysis , Adenocarcinoma/pathology , Barrett Esophagus/pathology , Biomarkers, Tumor/analysis , Esophageal Neoplasms/pathology , Humans , Immunohistochemistry , Sensitivity and Specificity
19.
Cancer ; 78(6): 1284-92, 1996 Sep 15.
Article in English | MEDLINE | ID: mdl-8826952

ABSTRACT

BACKGROUND: Transforming growth factor-alpha (TGF-alpha) and epidermal growth factor receptor (EGFR) mRNA are up-regulated in squamous cell carcinoma of the head and neck (SCCHN) tissues. METHODS: Immunohistochemical staining with monoclonal antibodies to TGF-alpha and EGFR was undertaken to identify the cellular origin in tissue obtained from cancer patients and controls and to determine the correlation between mRNA expression levels and two methods of immunohistochemical evaluation. RESULTS: TGF-alpha protein staining occurred in the suprabasal layers and spared the basal layer of normal controls. Conversely, in histologically normal mucosa from SCCHN patients, TGF-alpha was present throughout the epithelium, including the basal layer. EGFR staining was negligible in normal mucosa from control patients without cancer and relatively increased in SCCHN tissues. Increasing staining intensity was correlated with worsening dysplasia and closer proximity to the tumor. Using computerized image analysis to quantify the intensity of immunostaining, the mean optical density (MOD) of TGF-alpha staining in histologically normal mucosa (P = 0.049) and tumors (P = 0.005) from SCCHN patients was significantly higher than in control normal mucosa from noncancer patients (1.9- and 1.7-fold, respectively). EGFR MOD was also greater in the histologically normal mucosa (P = 0.009) and tumors (P = 0.006) from SCCHN patients than in control normal mucosa (1.8- and 1.9-fold, respectively). For both TGF-alpha (P = 0.668) and EGFR (P = 0.116), the MOD was similar for both tumor and histologically normal mucosa from SCCHN patients. CONCLUSIONS: TGF-alpha and EGFR protein expression is increased early in head and neck squamous cell carcinogenesis and can be quantitated by computerized image analysis of immunohistochemical staining. Altered distribution of TGF-alpha protein in histologically normal mucosa from SCCHN patients compared with control mucosa from patients without cancer suggests a switch from a paracrine to an autocrine pathway.


Subject(s)
Carcinoma, Squamous Cell/pathology , ErbB Receptors/analysis , Head and Neck Neoplasms/pathology , Tumor Necrosis Factor-alpha/analysis , Aged , Aged, 80 and over , Cell Nucleus/ultrastructure , Coloring Agents , Cytoplasm/ultrastructure , Epithelium/pathology , Female , Gene Expression Regulation, Neoplastic , Humans , Hypopharyngeal Neoplasms/pathology , Image Processing, Computer-Assisted , Immunohistochemistry , Laryngeal Neoplasms/pathology , Male , Middle Aged , Mouth Neoplasms/pathology , Mucous Membrane/pathology , RNA, Messenger/analysis , RNA, Messenger/genetics , Up-Regulation
20.
Mamm Genome ; 7(3): 188-93, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8833238

ABSTRACT

Ovarian teratomas are tumors that arise from female germ cells and are often a mixture of immature embryonal carcinoma cells and mature embryonic cells. Tissues derived from all three primary embryonic lineages (ectoderm, mesoderm, and endoderm) are typically found in the mature elements of a teratoma. In the case of the transgenic mouse line TG.KD, created with an imprinted transgene construct, malignant ovarian teratomas of a mixed germ cell tumor morphology occur in 15-20% of hemizygous female carriers of the transgene. The tumors frequently metastasize and can result in death of the mouse. Genetic analysis indicates that the tumors are associated with the transgenes integration site. Inbred FVB/N and female mice of other transgenic lines, also created in the inbred FVB/N strain with the same DNA construct as TG.KD, do not develop teratomas. In addition to teratomas, the integration of the transgene on Chromosome (Chr) 8 is associated with a perinatal lethality in homozygous transgenic carriers. The hemizygous genotypes of the teratomas suggest that they arise from early germ cells, prior to the completion of meiosis I.


Subject(s)
Genomic Imprinting/genetics , Mutagenesis, Insertional , Ovarian Neoplasms/genetics , Teratoma/genetics , Transgenes/genetics , Animals , Chromosome Mapping , Female , Genes, Lethal , Genotype , Heterozygote , Mice , Mice, Transgenic , Ovarian Neoplasms/embryology , Ovarian Neoplasms/pathology , Parthenogenesis , Teratocarcinoma/embryology , Teratocarcinoma/genetics , Teratocarcinoma/pathology , Teratoma/embryology , Teratoma/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...